Current perspective on antithrombin drugsMCGREGOR, John L.Pathophysiology of haemostasis and thrombosis (Print). 2002, Vol 32, pp 29-35, issn 1424-8832, 7 p., SUP3Conference Paper

Pomegranate fruit components modulate human thrombinCUCCIOLONI, M; MOZZICAFREDDO, M; SPARAPANI, L et al.Fitoterapia (Milano). 2009, Vol 80, Num 5, pp 301-305, issn 0367-326X, 5 p.Article

In-vitro evaluation of anti-factor IXa aptamer on thrombin generation, clotting time, and viscoelastometryTANAKA, Kenichi A; SZLAM, Fania; RUSCONI, Christopher P et al.Thrombosis and haemostasis. 2009, Vol 101, Num 5, pp 827-833, issn 0340-6245, 7 p.Article

The Argatroban and Tissue-Type Plasminogen Activator Stroke Study: Final Results of a Pilot Safety StudyBARRETO, Andrew D; ALEXANDROV, Andrei V; RAHBAR, Mohammad H et al.Stroke (1970). 2012, Vol 43, Num 3, pp 770-775, issn 0039-2499, 6 p.Article

Synthesis and biochemical evaluation of triazole/tetrazole-containing sulfonamides against thrombin and related serine proteasesSILES, Rogelio; KAWASAKI, Yuko; ROSS, Patrick et al.Bioorganic & medicinal chemistry letters (Print). 2011, Vol 21, Num 18, pp 5305-5309, issn 0960-894X, 5 p.Article

New ways to prevent venous thromboembolism: the pentasaccharide fondaparinux and the thrombin inhibitor ximelagatran: a reviewBERGQVIST, D.Acta chirurgica Belgica. 2005, Num 1, pp 35-39, issn 0001-5458, 5 p.Article